Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytek Biosciences (CTKB), Elanco Animal Health (ELAN) and Atara Biotherapeutics (ATRA)
Global Bovine Respiratory Disease Treatment Strategic Business Report 2024-2030 Featuring Bayer, Bimeda, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Merck, Vetoquinol, Virbac, & Zoetis
Elanco Animal Health Price Target Raised to $19.00/Share From $18.00 by Piper Sandler
Elanco Animal Health Price Target Raised to $19.00/Share From $18.00 by Piper Sandler
Piper Sandler: Reiterates the Elanco Animal Health (ELAN.US) rating, adjusted from neutral to neutral, and adjusted the target price from $18.00 to $19.00.
Piper Sandler: Reiterates the Elanco Animal Health (ELAN.US) rating, adjusted from neutral to neutral, and adjusted the target price from $18.00 to $19.00.
Piper Sandler Remains a Hold on Elanco Animal Health (ELAN)
U.S. Pledges Nearly $200M to Prevent Bird Flu Spread on Dairy Farms
Elanco Animal Health Stock (NYSE:ELAN) Hits 52-Week High, But Hurdles Remain
Elanco Animal Health Is Maintained at Overweight by Barclays
Elanco Animal Health Is Maintained at Overweight by Barclays
Elanco Animal Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 35.77% Barclays $19 → $23 Maintains Overweight 03/12/2024 6.26% Piper Sandler $12 → $18 Reitera
BofA Securities Adjusts Price Target on Elanco Animal Health to $20 From $18, Maintains Buy Rating
Elanco Animal Health (ELAN) has an average outperform rating and price target range of $16 to $23.00, according to analysts polled by Capital IQ. Price: 16.68, Change: -0.21, Percent Change: -1.24
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), IGM Biosciences (IGMS) and Elanco Animal Health (ELAN)
Elanco Animal Health First Quarter 2024 Earnings: Beats Expectations
Analysts' Top Healthcare Picks: Elanco Animal Health (ELAN), Syndax Pharmaceuticals (SNDX)
Elanco Animal Health Inc (ELAN) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Elanco Animal Health's Q1 Earnings Show Improved Base Business, Analyst Highlights Slightly Delayed But Encouraging Pipeline
Elanco Animal Health reports Q1 results: adjusted EPS $0.34 , sales $1.21B . 2024 guidance: EPS $0.88-$0.96, revenue $4.46-$4.52 billion.
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Upstart Holdings, Inc. (NASDAQ:UPST) fell sharply during Wednesday's session after the company reported first-quarter financial results and issued second-quarter revenue guidance below estim
Elanco Animal Health Up Nearly 24%, on Pace for Record Percent Increase -- Data Talk
Elanco Animal Health, Inc. (ELAN) is currently at $16.74, up $3.23 or 23.85% --Would be highest close since Aug. 19, 2022, when it closed at $17.47 --Would be largest percent increase on record (Bas
Update: Elanco Animal Health Shares Rise as Q1 Earnings, Revenue Beat Estimates
(Updates with stock price movement in the headline and first paragraph) Elanco Animal Health (ELAN) shares were up nearly 26% in recent Wednesday trading after the company reported its Q1 earnings. Th
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersMaxCyte (NASDAQ:MXCT) shares rose 26.5% to $4.97 during Wednesday's regular session. The company's market cap stands at $519.4 million. The company's, Q1 earnings came out yesterday. Elanco Ani
Elanco Surges on Q1 Beat, Anticipated Product Launches
No Data